Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution

Chemistry and Biology

Volumn 5, Issue 6, 1998, Pages 321-328

  Eyers, Patrick A ^a   Craxton, Molly ^b   Morrice, Nick ^a   Cohen, Philip ^a   Goedert, Michel ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Inflammation; Protein kinase inhibitors; SB 203580; Stress activated protein kinases; TGF receptor

Indexed keywords

EID: 0032102902     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(98)90170-3     Document Type: Article

References (32)

1. Ishii, H., et al., & King, G.L. (1996). Amelioration of vascular dysfunctions in diabetic rats by an oral PKC βinhibitor. Science 272, 728-731.
2. Uehata, M., et al., & Narumiya, S. (1997). Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389, 990-994.
3. Badger, A.M., Bradbeer, J.N., Votta, B., Lee, J.C., Adams, J.L. & Griswold, D.E. (1996). Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J. Pharmacol. Exp. Ther. 279, 1453-1461.
4. Lee, J.C., et al., & Young, P.R. (1994) A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372, 739-746.
5. Cuenda, A. et al., & Lee, J.C. (1995). SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364, 229-231.
6. Goedert, M., Cuenda A., Craxton, M., Jakes, R. & Cohen, P. (1997). Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases. EMBO J. 16, 3563-3571.
7. Cohen, P. (1997). The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol. 7, 353-361.
8. Han, J., Lee, J.-D., Bibbs, L. & Ulevitch, R.J. (1994). A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265, 808-811.
9. Rouse, J., et al., & Nebreda, A.R. (1994). A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell 78, 1027-1037.
10. Kumar, S., McDonnell, P.C., Gum, R.J., Hand, A.T., Lee, J.C. & Young, P.R. (1997) Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem. Biophys. Res. Commun. 235, 533-538.
11. Stein, B., et al., & Barbosa, M.S. (1997). p38-2, a novel mitogenactivated protein kinase with distinct properties. J. Biol. Chem. 272, 19509-19517.
12. Dérijard, B., et al., & Davis, R.J. (1994). JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-jun activation domain. Cell 76, 1025-1037.
13. Gupta, S., et al., & Davis, R.J. (1996). Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15, 2760-2770.
14. Mertens, S., Craxton, M. & Goedert, M. (1996.) SAP kinase-3, a new member of the family of mammalian stress-activated protein kinases. FEBS Lett. 383:273-276.
15. Lechner, C., Zahalka, M.A., Giot, J.-F., Moller, N.P.H. & Ullrich, A. (1996). ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. Proc. Natl Acad. Sci. USA 93, 4355-4359.
16. Li Z., Jiang, Y., Ulevitch, R.J. & Han, J (1996). The primary structure of p38γ: A new member of p38 group of MAP kinases. Biochem. Biophys. Res. Commun. 228, 334-340.
17. Cuenda, A., Cohen, P., Buée-Scherrer V. & Goedert, M. (1997). Activation of stress-activated protein kinase-3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38). EMBO J. 16, 295-305.
18. Wang, X.S., et al., & Yao, Z. (1997). Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase. J. Biol. Chem. 272, 23668-23674.
19. Jiang, Y., et al., & Han, J. (1997). Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinase, p38δ. J. Biol. Chem. 272, 30122-30128.
20. Young, P.R., et al., & Lee, J.C. (1997). Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP binding site. J. Biol. Chem. 272, 12116-12121.
21. Tong, L, et al., & Pargellis, C.A. (1997). A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket. Nat. Struct. Biol. 4, 311-316.
22. Wilson, K.P., et al., & Su, M.S.S. (1997). The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase. Chem. Biol. 4, 423-431.
23. Lin, H.Y., Wang, X.-F., Ng-Eaton, E., Weinberg, R.A. & Lodish HF (1992). Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68, 775-785.
24. Trevillyan, J.M., Lin, Y., Chen, S.J., Phillips, C.A., Canna, C. & Linna, T.J. (1986). Human T lymphocytes express a protein-tyrosine kinase homologous to p56LSTRA. Biochim. Biophys. Acta 888, 286-295.
25. Franzén, P., et al. & Miyazono, K. (1993). Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell 75, 681-692.
26. Gaskins, C., Maeda, M. & Firtel, R.A. (1994). Identification and functional analysis of a developmentally regulated extracellular signal-regulated kinase gene in Dictyostelium discoideum. Mol. Cell. Biol. 14, 6996-7012.
27. Whitmarsh, A.J., Yang, S.-H., Su, M.S.S., Sharrocks, A.D. & Davis, R.J. (1997). Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol. Cell. Biol. 17, 2360-2371.
28. Liu, Y., Shah, K., Yang, F., Witucki, L. & Shokat K.M. (1998). Engineering Src family protein kinases with unnatural nucleotide specificity. Chem. Biol. 5, 91-101.
29. Mohammadi, M., et al., & Schlessinger, J. (1997). Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors. Science 276, 955-960.
30. McKintosh, R.W., Dalby, K.N., Campbell, D.G., Cohen, P.T.W., Cohen, P. & McKintosh, C. (1995). The cyanobacterial toxin microcystin binds covalently to cysteine-273 on protein phosphatase 1. FEBS Lett. 371, 236-240.
31. Lawler, S., et al., & Derynck, R. (1997). The type II transforming growth factor-β receptor autophosphorylates not only on serine and threonine but also on tyrosine residues. J. Biol. Chem. 272, 14850-14859.
32. Alessi, D.R., Cohen, P., Ashworth, A., Cowley, S., Leevers, S.J. & Marshall, C.J. (1995). Assay and expression of mitogen-activated protein kinase, MAP kinase kinase, and Raf. Methods Enzymol. 255, 279-291.